Chronic inhibition of central angiotensin-converting enzyme ameliorates colchicine-induced memory impairment in mice

Scientia Pharmaceutica

Volumn 80, Issue 3, 2012, Pages 647-662

  Awasthi, Himani ^a,b   Kaushal, Deep ^a   Siddiqui, Hefazat Husain ^b  

^a AMITY UNIVERSITY   (India)

^b INTEGRAL UNIVERSITY   (India)

Author keywords

Acetylcholinesterase; Oxidative stress; Perindopril; Renin angiotensin system

Indexed keywords

ACETYLCHOLINESTERASE; COLCHICINE; DIPEPTIDYL CARBOXYPEPTIDASE; DONEPEZIL; GLUTATHIONE; MALONALDEHYDE; NITRITE; PERINDOPRIL; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DEMENTIA; DOSE RESPONSE; ENZYME INHIBITION; LATENT PERIOD; LOCOMOTION; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; SPATIAL MEMORY; TREATMENT DURATION;

EID: 84866490606     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1203-06     Document Type: Article

References (28)

1. Wright JW, Harding JW. The brain RAS and Alzheimer's disease. Exp Neurol. 2011; 223: 326-333. http://dx.doi.org/10.1016/j.expneurol.2009.09.012.
2. Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM. Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias. J Alzheimers Dis. 2011; 26: 699-708. http://www.ncbi.nlm.nih.gov/pubmed/21709373.
3. Fogari R, Mugellini A, Zoppi A, Derosa G, Pasotti C, Fogari E, Preti P. Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J Hum Hypertens. 2003; 17: 781-785. http://dx.doi.org/10.1038/sj.jhh.1001613.
4. Savaskan E, Hock C, Olivieri G, Bruttel S, Rosenberg C, Hulette C, Muller-Spahn F. Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia. Neurobiol Aging. 2001; 22: 541-546. http://dx.doi.org/10.1016/S0197-4580(00)00259-1.
5. Miners S, Ashby E, Baig S, Harrison R, Tayler H, Speedy E, Prince JA, Love S, Kehoe PG. Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res. 2009; 2: 163-177. http://www.ncbi.nlm.nih.gov/pubmed/19956428.
6. Miners JS, van Helmond Z, Raiker M, Love S, Kehoe PG. ACE variants and association with brain Abeta levels in Alzheimer's disease. Am J Transl Res. 2011; 3: 73-80. http://www.ncbi.nlm.nih.gov/pubmed/21139807.
7. Bulpitt CJ, Fletcher AE. Cognitive function and angiotensin-converting enzyme inhibitors in comparison with other antihypertensive drugs. J Cardiovasc Pharmacol. 1992; 19 (Suppl 6): S100-S104. http://dx.doi.org/10.1097/00005344-199219006-00016.
8. Gard PR, Rusted JM. Angiotensin and Alzheimer's disease: therapeutic prospects. Expert Rev Neurother. 2004; 4: 87-96. http://dx.doi.org/10.1586/14737175.4.1.87.
9. He M, Ohrui T, Maruyama M, Tomita N, Nakayama K, Higuchi M, Furukawa K, Arai H. ACE activity in CSF of patients with mild cognitive impairment and Alzheimer disease. Neurology. 2006; 67: 1309-1310. http://dx.doi.org/10.1212/01.wnl.0000238102.04582.ec.
10. Tota S, Hanif K, Kamat PK, Najmi AK, Nath C. Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function. Psychopharmacology. 2012; 222: 185-202. http://dx.doi.org/10.1007/s00213-012-2639-7.
11. Costall B, Coughlan J, Horovitz ZP, Kelly ME, Naylor RJ, Tomkins DM. The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition. Pharmacol Biochem Behav. 1989; 33: 573-579. http://dx.doi.org/10.1016/0091-3057(89)90390-0.
12. Tota S, Kamat PK, Saxena G, Hanif K, Najmi AK, Nath C. Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats. Behav Brain Res. 2011; 226: 317-330. http://dx.doi.org/10.1016/j.bbr.2011.07.047.
13. Tota, S., Nath C, Najmi A. K., Shukla R, Hanif K. Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: Role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism. Behav Brain Res. 2012; 232: 66-76. http://dx.doi.org/10.1016/j.bbr.2012.03.015.
14. Basso N, Paglia N, Stella I, de Cavanagh EM, Ferder L, del Rosario Lores Arnaiz M, Inserra F. Protective effect of the inhibition of the renin-angiotensin system on aging. Regul Pept. 2005; 128: 247-252. http://dx.doi.org/10.1016/j.regpep.2004.12.027.
15. Manschot SM, Biessels GJ, Cameron NE, Cotter MA, Kamal A, Kappelle LJ, Gispen WH. Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats. Brain Res. 2003; 966: 274-282. http://dx.doi.org/10.1016/S0006-8993(02)04211-7.
16. Hou DR, Wang Y, Zhou L, Chen K, Tian Y, Song Z, Bao J, Yang QD. Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease. Chin Med J (Engl). 2008; 121: 2320-2323. http://www.ncbi.nlm.nih.gov/pubmed/19080340.
17. Kumaran D, Udayabanu M, Kumar M, Aneja R, Katyal A. Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats. Neuroscience. 2008; 155: 626-639. http://dx.doi.org/10.1016/j.neuroscience.2008.06.023.
18. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 1995; 38: 357-366. http://dx.doi.org/10.1002/ana.410380304.
19. Bondy SC. The relation of oxidative stress and hyperexcitation to neurological disease. Proc Soc Exp Biol Med. 1995; 208: 337-345. http://www.ncbi.nlm.nih.gov/pubmed/7700883.
20. Kumar A, Dogra S, Prakash A. Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats. J Med Food. 2010; 13: 976-984. http://dx.doi.org/10.1089/jmf.2009.1251.
21. Kumar A, Seghal N, Naidu PS, Padi SS, Goyal R. Colchicines-induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type. Pharmacol Rep. 2007; 59: 274-283. http://www.ncbi.nlm.nih.gov/pubmed/17652827.
22. Yu Z, Cheng G, Hu B. Mechanism of colchicine impairment on learning and memory, and protective effect of CGP36742 in mice. Brain Res. 1997; 750: 53-58. http://dx.doi.org/10.1016/S0006-8993(96)01158-4.
23. Kumar A, Dogra S, Prakash A. Neuroprotective Effects of Centella asiatica against Intracerebroventricular Colchicine-Induced Cognitive Impairment and Oxidative Stress. Int J Alzheimers Dis. 2009; 2009: 972178. http://dx.doi.org/10.4061/2009/972178.
24. Awasthi H, Tota S, Hanif K, Nath C, Shukla R. Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow. Life Sci. 2010; 86: 87-94. http://dx.doi.org/10.1016/j.lfs.2009.11.007.
25. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82: 70-77. http://dx.doi.org/10.1016/0003-9861(59)90090-6.
26. Usui M, Egashira K, Kitamoto S, Koyanagi M, Katoh M, Kataoka C, Shimokawa H, Takeshita A. Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats. Hypertension. 1999; 34: 546-551. http://dx.doi.org/10.1161/01.HYP.34.4.546.
27. Emerich DF, Walsh TJ. Cholinergic cell loss and cognitive impairments following intraventricular or intradentate injection of colchicine. Brain Res. 1990; 517: 157-167. http://dx.doi.org/10.1016/0006-8993(90)91021-8.
28. Walsh TJ, Schulz DW, Tilson HA, Schmechel DE. Colchicine-induced granule cell loss in rat hippocampus: selective behavioral and histological alterations. Brain Res. 1986; 398: 23-36. http://dx.doi.org/10.1016/0006-8993(86)91246-1.